No abstract available
Keywords:
COVID‐19; SARS‐CoV‐2; neuropathy; polyradiculitis.
PubMed Disclaimer
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
-
da Silva GF, da Silva CF, Oliveira R, Romancini F, Mendes RM, Locks A, et al. Guillain‐Barré syndrome after coronavirus disease 2019 vaccine: a temporal association. Clin Exp Neuroimmunol. 2021. 10.1111/cen3.12678
-
DOI
-
PMC
-
PubMed
-
-
Yuan J, Zhang J, Zhang B, Hu W. The clinical features of patients concurrent with Guillain‐Barre syndrome and myasthenia gravis. Neurosciences (Riyadh). 2018;23(1):66–70. 10.17712/nsj.2018.1.20170209
-
DOI
-
PMC
-
PubMed
-
-
Gigli GL, Vogrig A, Nilo A, Fabris M, Biasotto A, Curcio F, et al. HLA and immunological features of SARS‐CoV‐2‐induced Guillain‐Barré syndrome. Neurol Sci. 2020;41(12):3391–4. 10.1007/s10072-020-04787-7
-
DOI
-
PMC
-
PubMed
-
-
Finsterer J. Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurol Scand. 2022;145(1):5–9. 10.1111/ane.13550
-
DOI
-
PMC
-
PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous